PRESS RELEASES

Year
May 11 | 2021
RAPT Therapeutics Reports First Quarter 2021 Financial Results
March 22 | 2021
RAPT Therapeutics Completes Enrollment in Phase 1b Trial of RPT193 in Atopic Dermatitis
March 11 | 2021
RAPT Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results
March 10 | 2021
RAPT Therapeutics to Report Promising Preclinical Studies Supporting its Pipeline of Immunotherapy Platforms at AACR
March 03 | 2021
RAPT Therapeutics to Participate in Two Investor Conferences in March
February 19 | 2021
RAPT Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
January 05 | 2021
RAPT Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
November 23 | 2020
RAPT Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 16 | 2020
RAPT Therapeutics Reports Third Quarter 2020 Financial Results
November 16 | 2020
RAPT Therapeutics Reports Positive Initial Data from Ongoing Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer Indications